Bank of America
IPCI

Bank of America’s Intellipharmaceuticals International Inc. IPCI Stock Holding History

Bank of America’s Portfolio IPCI Stock Details IPCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-1
Closed – – 7621
2018
Q2 		$0 Hold
1
– – ﹤0.01% 7505
2018
Q1 		$0 Hold
1
– – ﹤0.01% 7490
2017
Q4 		$0 Hold
1
– – ﹤0.01% 7414
2017
Q3 		$0 Sell
1
-1
-50% -$14 ﹤0.01% 7425
2017
Q2 		$0 Hold
2
– – ﹤0.01% 7320
2017
Q1 		$0 Buy
2
+1
+100% +$26 ﹤0.01% 7419
2016
Q4 		$0 Hold
1
– – ﹤0.01% 7516
2016
Q3 		$0 Hold
1
– – ﹤0.01% 7514
2016
Q2 		$0 Hold
1
– – ﹤0.01% 7561
2016
Q1 		$0 Hold
1
– – ﹤0.01% 7529
2015
Q4 		$0 Hold
1
– – ﹤0.01% 7588
2015
Q3 		$0 Sell
1
-42
-98% -$1.1K ﹤0.01% 7560
2015
Q2 		$1K Buy
43
+42
+4,200% +$1.27K ﹤0.01% 7172
2015
Q1 		$0 Sell
1
-10
-91% -$243 ﹤0.01% 7801
2014
Q4 		$0 Buy
11
+10
+1,000% +$270 ﹤0.01% 8142
2014
Q3 		$0 Sell
1
-110
-99% -$3.17K ﹤0.01% 8300
2014
Q2 		$4K Sell
111
-240
-68% -$9.24K ﹤0.01% 7724
2014
Q1 		$15K Sell
351
-50
-12% -$2K ﹤0.01% 7053
2013
Q4 		$15K Buy
401
+400
+40,000% +$10.7K ﹤0.01% 7155
2013
Q3 		$0 Hold
1
– – ﹤0.01% 8138
2013
Q2 		$0 Buy
+1
New +$18 ﹤0.01% 7821

Other funds holding IPCI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
FANJ
Financial Architects (New Jersey) Marlton, New Jersey $663M AUM 15.53% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Bank of America's IPCI Position: Q3 2018 in Review

Bank of America sold out of Intellipharmaceuticals International Inc. (IPCI) in Q3 2018, closing a stake of 1 share.

Bank of America first reported a position in IPCI in Q2 2013 and held it in 21 quarters. The position peaked at $15K in Q1 2014. 10 funds tracked by Wall St. Rank hold IPCI as of Q3 2018.

  • Bank of America reported no remaining Intellipharmaceuticals International Inc. position as of Q3 2018 after selling out during the quarter.
  • Bank of America sold 1 Intellipharmaceuticals International Inc. share in Q3 2018.
  • Bank of America first reported a position in Intellipharmaceuticals International Inc. in Q2 2013 and held it in 21 quarters.
  • Bank of America's Intellipharmaceuticals International Inc. position peaked at $15K in Q1 2014.
  • 10 funds tracked by Wall St. Rank held Intellipharmaceuticals International Inc. as of Q3 2018.

Based on Bank of America's 13F filing for Q3 2018, filed 14 Nov 2018.